Home » Products » Anti Cancer Medicine » Lapatinib Tablet

Lapatinib Tablet

Lapatinib Tablet
Lapatinib Tablet
Send Inquiry
Product Code : asp
Brand Name : Tykerb
Price And Quantity
  • Minimum Order Quantity
  • 10
  • Unit of Measure
  • Box/Boxes
  • Price
  • 1 USD ($)
Product Specifications
  • Drug Type
  • Other Types
  • Ingredients
  • Lapatinib
  • Physical Form
  • Tablets
  • Dosage
  • Tablets
  • Quantity
  • 10 Boxes
Product Description

Aspar® Pharmaceuticals is a leading manufacturer and exporter of

Lapatinib 250mg Tablet

in different strength and packing. Our manufacturing facility is certified with WHO-GMP.



Lapatinib 250mg Tablet


Brand Name: Tykerb 250mg Tablets

Active Ingredients (Generic Name): Lapatinib 250mg

Company name: Novartis Pharma Ltd

Strength: 250 mg

Pack Type: Bottle

Pack Size: 30 Tabs



Lapatinib 250mg Tablet

Lapatinib 250mg Tablet is used in the treatment of Breast Cancer. 



Lapatinib 250mg Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lapatinib 250mg Tablet is to be taken empty stomach. 


How it works:-

Lapatinib 250mg Tablet

Lapatinib 250mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.


Available other Brand :

We are manufacture and export of our brand. We also offer private labeling, Contract manufacturing service.

Additional Information:

  • Delivery Time: 10 Days

Trade Information
  • FOB Port
  • mumbai
  • Payment Terms
  • Others, Western Union
  • Delivery Time
  • 10 Days
  • Sample Policy
  • Contact us for information regarding our sample policy
  • Packaging Details
  • 30 Film-coated Tablets
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia


ASPAR PHARMACEUTICALS All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.